hero section gradient
23 handpicked stocks

Pharma

Health is wealth, and these carefully selected pharmaceutical companies could help your portfolio grow. Our professional analysts have handpicked these stocks from an industry that's projected to reach $1.9 trillion by 2027.

Author avatar

Han Tan | Market Analyst

Published on May 6

Your Basket's Financial Footprint

Summary of market cap composition for the Pharma basket.

Key Takeaways for Investors:
  • Large-cap dominance suggests generally lower volatility and more stable returns, closely tracking broad market healthcare performance.
  • Suitable as a core, long-term holding for diversified portfolios rather than a speculative or high-conviction growth position.
  • Expect steady, incremental appreciation over time; less likely to deliver explosive short-term gains.
Total Market Cap
  • JNJ: $462.30B

  • PFE: $141.29B

  • MRNA: $10.74B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Pharmaceutical companies offer a unique combination of stability and growth potential. With consistent demand for healthcare and ongoing innovation in treatments, this industry is projected to grow at 7% annually, reaching $1.9 trillion by 2027.

2

What You Need to Know

These pharma stocks represent companies focused on developing life-improving and life-saving medications. The healthcare sector tends to be more resilient during economic downturns, as medical needs remain constant regardless of market conditions.

3

Why These Stocks

This collection includes established pharmaceutical giants alongside innovative biotech companies. These stocks were selected based on their market leadership, research capabilities, and potential for growth through new treatments and medications.

Why You'll Want to Watch These Stocks

💊

Healthcare's Golden Opportunity

The pharma industry is expected to reach $1.9 trillion by 2027. Getting in now means you could benefit from this massive growth trajectory as companies develop new treatments.

🔬

Innovation Worth Watching

Companies like Moderna and Novavax showed how pharmaceutical breakthroughs can lead to extraordinary gains. These stocks represent the future of healthcare innovation.

📈

Recession-Resistant Potential

Healthcare needs remain constant regardless of economic conditions, making pharma stocks potentially more stable during market downturns while still offering growth.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Digital Trust Stocks | Cybersecurity Investment Opportunity

Digital Trust Stocks | Cybersecurity Investment Opportunity

Fifteen global tech giants, led by Microsoft and Ericsson, have formed an alliance to establish a common framework for digital trust and security. This move signals a growing demand for specialized cybersecurity and verification technologies, creating an investment opportunity in companies that provide the essential tools for a trusted digital ecosystem.

Food Safety Stocks: What's Next After Costco Lawsuit

Food Safety Stocks: What's Next After Costco Lawsuit

A recent lawsuit against Costco regarding salmonella in its rotisserie chicken has intensified focus on food safety across the grocery industry. This creates a potential investment opportunity in companies that provide testing, diagnostics, and supply chain verification services.

Founder-Controlled Stocks May Gain Focus in 2025

Founder-Controlled Stocks May Gain Focus in 2025

SpaceX is reportedly considering a dual-class share structure for its IPO to ensure founder Elon Musk retains control. This move could spark investor interest in other public companies where founders or insiders hold significant voting power through similar stock structures.

Frequently Asked Questions